Eyal Morag, MD

CMO
Impact Biotech, Israel

Presentation(s):

• Intra-Arterial (IA) Padeliporfin Vascular-Targeted Photodynamic Therapy (VTP): Ongoing Multicenter, Phase I Light Dose Escalation Study in Unresectable Locally Advanced Pancreatic Ductal Adenocarcinoma (LA-PDAC)

  Monday, April 13, 2026
  4:21 PM - 4:30 PM ET